US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Immatics N.V.

9.40

-0.1300-1.36%

Volume:181.32K

Turnover:1.70M

Market Cap:1.41B

PE:-5.14

High:9.60

Open:9.38

Low:9.23

Close:9.53

52wk High:12.41

52wk Low:5.05

Shares:150.00M

Float Shares:83.07M

Volume Ratio:0.49

T/O Rate:0.22%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8285

EPS(LYR):-1.8903

ROE:-47.80%

ROA:-26.92%

PB:3.04

PE(LYR):-4.97

Loading ...

Overview Company News Filings

Immatics announces annual general meeting

Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting

Immatics announces presentation of extended data from Phase 1 trial of IMA401

Immatics announces updated Phase 1 data for its Prame TCR T-cell therapy

Immatics presents Phase 1 data for IMA401 MAGEA4/8 bispecific at ASCO 2026, supporting lung cancer combo study with IMA402

Immatics posts ASCO presentation on PRAME-targeted TCR-T therapies in synovial sarcoma

Immatics reports 63% response rate in Phase 1 trial of IMA203CD8 PRAME T-cell therapy in hard-to-treat gynecologic cancers

Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting

How Investors May Respond To Immatics (IMTX) Wider Q1 Loss And Rising Funding Needs

Simply Wall St.

Immatics Is Maintained at Buy by Chardan Capital

Chardan Capital Reaffirms Their Buy Rating on Immatics (IMTX)

Immatics N.V. (NASDAQ:IMTX) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Immatics (IMTX) and Cormedix (CRMD)

Stock Track | Immatics Soars 5.18% in Pre-market After Goldman Sachs Maintains Buy Rating

Immatics (IMTX) Gets a Buy from Goldman Sachs

Immatics NV reports results for the quarter ended March 31 - Earnings Summary

Immatics Q1 Loss Widens, Revenue Falls

MT Newswires Live

Immatics Q1 EPS $(0.50) Misses $(0.42) Estimate, Sales $8.914M Miss $14.590M Estimate

Benzinga Earnings

Earnings Flash (IMTX) Immatics Posts Q1 Net Loss 0.43 Euro a Share, vs. FactSet Est of 0.45 Euro Loss

MT Newswires Live

Press Release: Immatics Announces First Quarter 2026 Financial Results and Business Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/IMTX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMTX\",,,,,undefined,":{"symbol":"IMTX","market":"US","secType":"STK","nameCN":"Immatics N.V.","latestPrice":9.4,"timestamp":1788279235837,"preClose":9.53,"halted":0,"volume":181321,"delay":0,"changeRate":-0.0136411332633787,"floatShares":83065400,"shares":150000000,"eps":-1.828543,"marketStatus":"Trading","change":-0.13,"latestTime":"09-01 12:14:15 EDT","open":9.38,"high":9.6,"low":9.23,"amount":1698643.3234155,"amplitude":0.038825,"askPrice":9.41,"askSize":10,"bidPrice":9.4,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-1.828543,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":9.53,"preHourTrading":{"tag":"盘前","latestPrice":9.53,"preClose":9.53,"latestTime":"08:41 EDT","volume":21657,"amount":206391.21,"timestamp":1788266461529,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":9.62,"preClose":9.53,"latestTime":"19:34 EDT","volume":12595,"amount":120152.942,"timestamp":1788219249382,"change":0.09,"changeRate":0.009444,"amplitude":0.01469},"volumeRatio":0.486627,"impliedVol":0.8624,"impliedVolPercentile":0.8175},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMTX\",,,,,undefined,":{"symbol":"IMTX","floatShares":83065400,"roa":"-26.92%","roe":"-47.80%","lyrEps":-1.890337,"volumeRatio":0.486627,"shares":150000000,"dividePrice":0,"high":9.6,"amplitude":0.038825,"preClose":9.53,"low":9.23,"week52Low":5.05,"pbRate":"3.04","psRate":"29.17","week52High":12.41,"institutionHeld":0,"latestPrice":9.4,"committee":-0.333333,"eps":-1.828543,"divideRate":0,"volume":181321,"delay":0,"ttmEps":-1.828543,"open":9.38,"prevYearClose":10.5,"prevWeekClose":9.45,"prevMonthClose":9.53,"prevQuarterClose":10.13,"fiveDayClose":9.24,"twentyDayClose":9.38,"sixtyDayClose":9.79},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-18","symbol":"IMTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.43,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1787025600000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2026-05-12","symbol":"IMTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.42,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.5},{"market":"US","date":"2026-03-05","symbol":"IMTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.48,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2025-11-17","symbol":"IMTX","fiscalQuarterEnding":"2025/09","expectedEps":-0.5,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763355600000,"reportTimeType":"pre","actualEps":-0.49},{"market":"US","date":"2025-08-13","symbol":"IMTX","fiscalQuarterEnding":"2025/06","expectedEps":-0.38,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.66}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":10,"updateTime":1777608000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMTX","date":"2026-08-31","current":-5.146174,"percent":0.644662,"low":-31.692243,"twenty":-13.315327,"median":-8.07982,"eighty":13.654465,"high":52.423212,"avg":-2.706164,"sd":16.153331,"marketCap":1291720282},"quantilePoints":[{"date":"2021-09-03","current":-3.078582,"twenty":-10.825855,"median":-4.251397,"eighty":-2.7773,"marketCap":846129156},{"date":"2021-09-10","current":-3.403285,"twenty":-10.790247,"median":-4.250474,"eighty":-2.777529,"marketCap":931056618},{"date":"2021-09-17","current":-3.392377,"twenty":-10.691215,"median":-4.247741,"eighty":-2.777764,"marketCap":920991141},{"date":"2021-09-24","current":-3.054626,"twenty":-10.461433,"median":-4.241417,"eighty":-2.778107,"marketCap":827256387},{"date":"2021-10-01","current":-3.101811,"twenty":-10.269118,"median":-4.237908,"eighty":-2.779902,"marketCap":831660033},{"date":"2021-10-08","current":-3.149511,"twenty":-10.241998,"median":-4.237091,"eighty":-2.782903,"marketCap":842983695},{"date":"2021-10-15","current":-3.247368,"twenty":-10.205714,"median":-4.233676,"eighty":-2.784427,"marketCap":871292849},{"date":"2021-10-22","current":-3.039938,"twenty":-10.125613,"median":-4.233096,"eighty":-2.785075,"marketCap":817820003},{"date":"2021-10-29","current":-3.370826,"twenty":-10.024677,"median":-4.229188,"eighty":-2.78616,"marketCap":901489280},{"date":"2021-11-05","current":-2.942397,"twenty":-9.974683,"median":-4.223703,"eighty":-2.789063,"marketCap":786365387},{"date":"2021-11-12","current":-2.77511,"twenty":-9.944768,"median":-4.219278,"eighty":-2.784427,"marketCap":734779818},{"date":"2021-11-19","current":-6.990131,"twenty":-9.935725,"median":-4.221572,"eighty":-2.785075,"marketCap":747990756},{"date":"2021-11-26","current":-6.599226,"twenty":-9.905963,"median":-4.226162,"eighty":-2.785784,"marketCap":705841571},{"date":"2021-12-03","current":-6.409284,"twenty":-9.794701,"median":-4.2311,"eighty":-2.788174,"marketCap":683823340},{"date":"2021-12-10","current":-6.406581,"twenty":-9.76449,"median":-4.233096,"eighty":-2.792231,"marketCap":685081525},{"date":"2021-12-17","current":-7.254739,"twenty":-9.712928,"median":-4.234578,"eighty":-2.794332,"marketCap":773154448},{"date":"2021-12-23","current":-7.622634,"twenty":-9.708361,"median":-4.237381,"eighty":-2.794695,"marketCap":815303633},{"date":"2021-12-31","current":-7.865595,"twenty":-9.622233,"median":-4.238088,"eighty":-2.796731,"marketCap":845500064},{"date":"2022-01-07","current":-7.031083,"twenty":-9.546567,"median":-4.241719,"eighty":-2.800489,"marketCap":753652587},{"date":"2022-01-14","current":-6.916751,"twenty":-7.865595,"median":-4.249358,"eighty":-2.800946,"marketCap":746732571},{"date":"2022-01-21","current":-6.161768,"twenty":-7.671226,"median":-4.250474,"eighty":-2.809235,"marketCap":660546925},{"date":"2022-01-28","current":-5.682608,"twenty":-7.598192,"median":-4.252066,"eighty":-2.811315,"marketCap":599524971},{"date":"2022-02-04","current":-5.415102,"twenty":-7.577765,"median":-4.260964,"eighty":-2.815431,"marketCap":585684940},{"date":"2022-02-11","current":-5.368879,"twenty":-7.55929,"median":-4.265136,"eighty":-2.817527,"marketCap":578764925},{"date":"2022-02-18","current":-5.068408,"twenty":-7.525825,"median":-4.268884,"eighty":-2.818188,"marketCap":542906663},{"date":"2022-02-25","current":-4.826526,"twenty":-7.515544,"median":-4.26941,"eighty":-2.818529,"marketCap":513968417},{"date":"2022-03-04","current":-4.347856,"twenty":-7.511944,"median":-4.293256,"eighty":-2.819562,"marketCap":448542817},{"date":"2022-03-11","current":-4.304171,"twenty":-7.448338,"median":-4.305998,"eighty":-2.820154,"marketCap":445397355},{"date":"2022-03-18","current":-4.344111,"twenty":-7.369572,"median":-4.305066,"eighty":-2.820854,"marketCap":454204647},{"date":"2022-03-25","current":-4.589675,"twenty":-7.333179,"median":-4.305998,"eighty":-2.821862,"marketCap":470692583},{"date":"2022-04-01","current":-5.082095,"twenty":-7.316094,"median":-4.316795,"eighty":-2.823208,"marketCap":523551109},{"date":"2022-04-08","current":-5.808116,"twenty":-7.276796,"median":-4.322149,"eighty":-2.826467,"marketCap":589624265},{"date":"2022-04-14","current":-5.439892,"twenty":-7.239301,"median":-4.32306,"eighty":-2.828244,"marketCap":548721835},{"date":"2022-04-22","current":-4.94738,"twenty":-7.214962,"median":-4.328603,"eighty":-2.829137,"marketCap":497751114},{"date":"2022-04-29","current":-4.970873,"twenty":-7.204094,"median":-4.330485,"eighty":-2.830458,"marketCap":488941360},{"date":"2022-05-06","current":-4.753766,"twenty":-7.176002,"median":-4.332311,"eighty":-2.830802,"marketCap":470063315},{"date":"2022-05-13","current":-4.456228,"twenty":-7.151643,"median":-4.330965,"eighty":-2.833601,"marketCap":432936494},{"date":"2022-05-20","current":-4.511889,"twenty":-7.146817,"median":-4.330685,"eighty":-2.837505,"marketCap":444263320},{"date":"2022-05-27","current":-4.593904,"twenty":-7.14247,"median":-4.333658,"eighty":-2.838986,"marketCap":459365756},{"date":"2022-06-03","current":30.984059,"twenty":-7.132436,"median":-4.333658,"eighty":-2.837386,"marketCap":502785259},{"date":"2022-06-10","current":31.47958,"twenty":-7.095217,"median":-4.330685,"eighty":-2.828721,"marketCap":501526723},{"date":"2022-06-17","current":31.340684,"twenty":-7.028991,"median":-4.330104,"eighty":-2.821498,"marketCap":496492578},{"date":"2022-06-24","current":33.767511,"twenty":-7.020624,"median":-4.326984,"eighty":-2.818691,"marketCap":539282813},{"date":"2022-07-01","current":35.603419,"twenty":-6.990131,"median":-4.32251,"eighty":-2.811317,"marketCap":560677930},{"date":"2022-07-08","current":37.079023,"twenty":-6.982068,"median":-4.318801,"eighty":-2.799737,"marketCap":571375489},{"date":"2022-07-15","current":35.505105,"twenty":-6.956118,"median":-4.309822,"eighty":-2.79084,"marketCap":542429153},{"date":"2022-07-22","current":41.714294,"twenty":-6.945556,"median":-4.305066,"eighty":-2.78373,"marketCap":645629132},{"date":"2022-07-29","current":45.230997,"twenty":-6.922283,"median":-4.290877,"eighty":-2.777636,"marketCap":698487657},{"date":"2022-08-05","current":50.949399,"twenty":-6.871415,"median":-4.269405,"eighty":-2.776318,"marketCap":783438859},{"date":"2022-08-12","current":27.106142,"twenty":-6.816854,"median":-4.268884,"eighty":-2.77414,"marketCap":769661015},{"date":"2022-08-19","current":26.712244,"twenty":-6.779088,"median":-4.265136,"eighty":-2.771962,"marketCap":742713020},{"date":"2022-08-26","current":29.255019,"twenty":-6.76857,"median":-4.260964,"eighty":-2.760462,"marketCap":809754373},{"date":"2022-09-02","current":29.099514,"twenty":-6.760787,"median":-4.252066,"eighty":-2.743934,"marketCap":808439836},{"date":"2022-09-09","current":30.376313,"twenty":-6.731993,"median":-4.250666,"eighty":-2.736256,"marketCap":844589585},{"date":"2022-09-16","current":24.534422,"twenty":-6.693707,"median":-4.249358,"eighty":-2.723454,"marketCap":680929813},{"date":"2022-09-23","current":22.091514,"twenty":-6.6761,"median":-4.241719,"eighty":-2.715954,"marketCap":594827684},{"date":"2022-09-30","current":24.204025,"twenty":-6.628877,"median":-4.238088,"eighty":-2.713859,"marketCap":657268160},{"date":"2022-10-07","current":24.496099,"twenty":-6.594613,"median":-4.237381,"eighty":-2.706734,"marketCap":663183573},{"date":"2022-10-14","current":31.322778,"twenty":-6.589488,"median":-4.233884,"eighty":-2.696602,"marketCap":845357851},{"date":"2022-10-21","current":29.805292,"twenty":-6.528128,"median":-4.233096,"eighty":-2.690126,"marketCap":809531143},{"date":"2022-10-28","current":32.056496,"twenty":-6.446437,"median":-4.229631,"eighty":-2.6827,"marketCap":882709100},{"date":"2022-11-04","current":29.1286,"twenty":-6.413026,"median":-4.224933,"eighty":-2.660513,"marketCap":799621628},{"date":"2022-11-11","current":27.876343,"twenty":-6.407662,"median":-4.219678,"eighty":-2.631297,"marketCap":797334817},{"date":"2022-11-18","current":22.85251,"twenty":-6.397511,"median":-4.217842,"eighty":-2.615585,"marketCap":804195250},{"date":"2022-11-25","current":21.75977,"twenty":-6.38329,"median":-4.21567,"eighty":-2.607848,"marketCap":768368543},{"date":"2022-12-02","current":24.104844,"twenty":-6.362064,"median":-4.213063,"eighty":-2.583683,"marketCap":858316447},{"date":"2022-12-09","current":22.236944,"twenty":-6.324978,"median":-4.209186,"eighty":-2.564912,"marketCap":795810276},{"date":"2022-12-16","current":19.179624,"twenty":-6.280319,"median":-4.191914,"eighty":-2.546275,"marketCap":690616964},{"date":"2022-12-23","current":17.984734,"twenty":-6.2531,"median":-4.158373,"eighty":-2.499541,"marketCap":648692093},{"date":"2022-12-30","current":18.294011,"twenty":-6.2237,"median":-4.117121,"eighty":-2.484761,"marketCap":663937500},{"date":"2023-01-06","current":19.964997,"twenty":-6.186645,"median":-4.100495,"eighty":-2.471857,"marketCap":719583238},{"date":"2023-01-13","current":18.257856,"twenty":-6.161768,"median":-4.023422,"eighty":-2.458237,"marketCap":670797934},{"date":"2023-01-20","current":18.041801,"twenty":-6.079076,"median":-3.96391,"eighty":-2.405656,"marketCap":663937500},{"date":"2023-01-27","current":16.376959,"twenty":-6.008249,"median":-3.657748,"eighty":16.911505,"marketCap":603718140},{"date":"2023-02-03","current":17.25105,"twenty":-5.989564,"median":-3.558838,"eighty":17.08934,"marketCap":635733496},{"date":"2023-02-10","current":17.382853,"twenty":-5.953314,"median":-3.438244,"eighty":17.270208,"marketCap":630397604},{"date":"2023-02-17","current":18.482422,"twenty":-5.918854,"median":-3.392377,"eighty":17.354042,"marketCap":669273393},{"date":"2023-02-24","current":18.36038,"twenty":-5.894522,"median":-3.372497,"eighty":17.451261,"marketCap":657839337},{"date":"2023-03-03","current":18.19044,"twenty":-5.881075,"median":-3.358332,"eighty":17.71626,"marketCap":654790256},{"date":"2023-03-10","current":16.142363,"twenty":-5.864714,"median":-3.335676,"eighty":17.672758,"marketCap":584661381},{"date":"2023-03-17","current":16.00357,"twenty":-5.826663,"median":-3.263668,"eighty":17.645234,"marketCap":579325488},{"date":"2023-03-24","current":12.805368,"twenty":-5.80685,"median":-3.247368,"eighty":17.624454,"marketCap":516760511},{"date":"2023-03-31","current":12.979613,"twenty":-5.803928,"median":-3.221336,"eighty":17.568227,"marketCap":529027823},{"date":"2023-04-06","current":12.071159,"twenty":-5.793921,"median":-3.198834,"eighty":17.479946,"marketCap":494526008},{"date":"2023-04-14","current":11.687072,"twenty":-5.748747,"median":-3.158998,"eighty":17.390107,"marketCap":484558817},{"date":"2023-04-21","current":13.360022,"twenty":-5.698062,"median":-3.156078,"eighty":17.383799,"marketCap":549728911},{"date":"2023-04-28","current":12.683615,"twenty":-5.691819,"median":-3.152411,"eighty":17.368447,"marketCap":524427581},{"date":"2023-05-05","current":17.979587,"twenty":-5.685652,"median":-3.147161,"eighty":17.383799,"marketCap":742172366},{"date":"2023-05-12","current":17.725017,"twenty":-5.671641,"median":-3.138368,"eighty":17.629385,"marketCap":726071519},{"date":"2023-05-19","current":-10.151786,"twenty":-5.698062,"median":-3.141798,"eighty":17.629385,"marketCap":742172366},{"date":"2023-05-26","current":-9.950166,"twenty":-5.807272,"median":-3.150512,"eighty":17.583682,"marketCap":724545816},{"date":"2023-06-02","current":-10.644199,"twenty":-5.88209,"median":-3.154446,"eighty":17.50863,"marketCap":775915731},{"date":"2023-06-09","current":-11.308694,"twenty":-5.994173,"median":-3.157482,"eighty":17.391999,"marketCap":827285646},{"date":"2023-06-16","current":-12.229027,"twenty":-6.2237,"median":-3.166035,"eighty":17.384114,"marketCap":907024022},{"date":"2023-06-23","current":-12.147736,"twenty":-6.348619,"median":-3.204791,"eighty":17.382853,"marketCap":903957161},{"date":"2023-06-30","current":-12.04225,"twenty":-6.407122,"median":-3.221768,"eighty":17.354042,"marketCap":890156289},{"date":"2023-07-07","current":-12.184138,"twenty":-6.528128,"median":-3.247368,"eighty":17.341363,"marketCap":898590155},{"date":"2023-07-14","current":-11.238993,"twenty":-6.6761,"median":-3.263668,"eighty":17.285715,"marketCap":854120677},{"date":"2023-07-21","current":-12.026416,"twenty":-6.769514,"median":-3.335676,"eighty":17.248922,"marketCap":910090883},{"date":"2023-07-28","current":-12.13641,"twenty":-6.927815,"median":-3.358332,"eighty":17.237248,"marketCap":905595762},{"date":"2023-08-04","current":-13.426534,"twenty":-7.002328,"median":-3.372497,"eighty":17.188775,"marketCap":998132622},{"date":"2023-08-11","current":-12.711176,"twenty":-7.140891,"median":-3.397831,"eighty":17.146948,"marketCap":950677822},{"date":"2023-08-18","current":-11.575451,"twenty":-7.199545,"median":-3.466763,"eighty":17.132005,"marketCap":988754849},{"date":"2023-08-25","current":-13.773824,"twenty":-7.316094,"median":-3.566852,"eighty":17.116447,"marketCap":1012860091},{"date":"2023-09-01","current":-13.315817,"twenty":-7.511944,"median":-3.71005,"eighty":17.094142,"marketCap":980561200},{"date":"2023-09-08","current":-14.294273,"twenty":-7.566738,"median":-3.96391,"eighty":17.063843,"marketCap":1038533569},{"date":"2023-09-15","current":-11.983645,"twenty":-8.874178,"median":-4.043994,"eighty":17.004477,"marketCap":1003750148},{"date":"2023-09-22","current":-11.720432,"twenty":-9.751885,"median":-4.109182,"eighty":16.936748,"marketCap":981389377},{"date":"2023-09-29","current":-10.989479,"twenty":-9.944768,"median":-4.127732,"eighty":16.882928,"marketCap":911822535},{"date":"2023-10-06","current":-9.736738,"twenty":-9.950021,"median":-4.187015,"eighty":16.840156,"marketCap":804987742},{"date":"2023-10-13","current":-9.246417,"twenty":-9.950166,"median":-4.192623,"eighty":16.764801,"marketCap":766063438},{"date":"2023-10-20","current":-8.69547,"twenty":-9.950166,"median":-4.209221,"eighty":16.760739,"marketCap":722170073},{"date":"2023-10-27","current":-7.811787,"twenty":-9.949876,"median":-4.209669,"eighty":16.753851,"marketCap":645977818},{"date":"2023-11-03","current":-8.126794,"twenty":-9.944768,"median":-4.214289,"eighty":16.596896,"marketCap":677448532},{"date":"2023-11-10","current":-8.91985,"twenty":-9.935725,"median":-4.217622,"eighty":16.372628,"marketCap":750328081},{"date":"2023-11-17","current":-7.878904,"twenty":-9.893586,"median":-4.219278,"eighty":16.338091,"marketCap":719576969},{"date":"2023-11-24","current":-7.783463,"twenty":-9.828027,"median":-4.222638,"eighty":16.275259,"marketCap":713651041},{"date":"2023-12-01","current":-8.161128,"twenty":-9.800117,"median":-4.228744,"eighty":16.184694,"marketCap":748360047},{"date":"2023-12-08","current":-8.576782,"twenty":-9.799205,"median":-4.232832,"eighty":16.152281,"marketCap":777989687},{"date":"2023-12-15","current":-8.974386,"twenty":-9.796468,"median":-4.233469,"eighty":16.128299,"marketCap":829629917},{"date":"2023-12-22","current":-8.829807,"twenty":-9.784165,"median":-4.236182,"eighty":16.058348,"marketCap":816084938},{"date":"2023-12-29","current":-9.817282,"twenty":-9.788566,"median":-4.237672,"eighty":16.017264,"marketCap":914286031},{"date":"2024-01-05","current":-9.84926,"twenty":-9.799179,"median":-4.237908,"eighty":15.787784,"marketCap":907513542},{"date":"2024-01-12","current":-11.164921,"twenty":-9.827882,"median":-4.241417,"eighty":15.001283,"marketCap":1027725223},{"date":"2024-01-19","current":-10.509102,"twenty":-9.923982,"median":-4.246124,"eighty":14.286891,"marketCap":960000332},{"date":"2024-01-26","current":-13.2552,"twenty":-9.975151,"median":-4.250072,"eighty":14.128591,"marketCap":1207836504},{"date":"2024-02-02","current":-12.813281,"twenty":-10.037818,"median":-4.251397,"eighty":13.812661,"marketCap":1168707956},{"date":"2024-02-09","current":-12.856476,"twenty":-10.222322,"median":-4.259137,"eighty":13.7688,"marketCap":1163559463},{"date":"2024-02-16","current":-13.079682,"twenty":-10.275151,"median":-4.264663,"eighty":13.665929,"marketCap":1183123737},{"date":"2024-02-23","current":-13.654695,"twenty":-10.375786,"median":-4.268026,"eighty":13.620071,"marketCap":1241816559},{"date":"2024-03-01","current":-14.17339,"twenty":-10.455919,"median":-4.269172,"eighty":13.553642,"marketCap":1288152998},{"date":"2024-03-08","current":-13.536794,"twenty":-10.575044,"median":-4.290428,"eighty":13.456429,"marketCap":1243875957},{"date":"2024-03-15","current":-13.492704,"twenty":-10.763426,"median":-4.299903,"eighty":13.415921,"marketCap":1235638368},{"date":"2024-03-22","current":-11.086407,"twenty":-10.867718,"median":-4.305998,"eighty":13.360022,"marketCap":1167678257},{"date":"2024-03-28","current":-10.911126,"twenty":-10.925248,"median":-4.315583,"eighty":13.32787,"marketCap":1143134299},{"date":"2024-04-05","current":-10.46863,"twenty":-10.912877,"median":-4.320871,"eighty":13.271395,"marketCap":1102970121},{"date":"2024-04-12","current":-10.746475,"twenty":-10.908955,"median":-4.32306,"eighty":13.035548,"marketCap":1116358180},{"date":"2024-04-19","current":-10.216144,"twenty":-10.905758,"median":-4.328603,"eighty":12.961563,"marketCap":1056626838},{"date":"2024-04-26","current":-9.693544,"twenty":-10.896881,"median":-4.330485,"eighty":12.913552,"marketCap":1007194004},{"date":"2024-05-03","current":-10.807607,"twenty":-10.879543,"median":-4.332311,"eighty":12.860181,"marketCap":1121507434},{"date":"2024-05-10","current":-10.484937,"twenty":-10.869319,"median":-4.334837,"eighty":12.814206,"marketCap":1095761166},{"date":"2024-05-17","current":-12.7546,"twenty":-10.896881,"median":-4.338204,"eighty":12.715202,"marketCap":1113268628},{"date":"2024-05-24","current":-11.635627,"twenty":-10.925248,"median":-4.342323,"eighty":12.685424,"marketCap":1011313407},{"date":"2024-05-31","current":-13.340974,"twenty":-10.974707,"median":-4.344256,"eighty":12.661618,"marketCap":1161671612},{"date":"2024-06-07","current":-15.899402,"twenty":-11.04942,"median":-4.350296,"eighty":12.570972,"marketCap":1389268621},{"date":"2024-06-14","current":-15.429036,"twenty":-11.088795,"median":-4.359855,"eighty":12.514994,"marketCap":1333656682},{"date":"2024-06-21","current":-14.876445,"twenty":-11.111953,"median":-4.367595,"eighty":12.453321,"marketCap":1280104444},{"date":"2024-06-28","current":-14.124091,"twenty":-11.132225,"median":-4.368555,"eighty":12.345948,"marketCap":1214193998},{"date":"2024-07-05","current":-14.022083,"twenty":-11.163115,"median":-4.371132,"eighty":12.197292,"marketCap":1217283551},{"date":"2024-07-12","current":-14.440272,"twenty":-11.194906,"median":-4.381212,"eighty":12.109683,"marketCap":1260537281},{"date":"2024-07-15","current":-14.922697,"twenty":-11.204521,"median":-4.382481,"eighty":12.096841,"marketCap":1307910414},{"date":"2024-08-02","current":-14.043542,"twenty":-11.217935,"median":-4.38375,"eighty":12.084,"marketCap":1216253700},{"date":"2024-08-09","current":-13.401026,"twenty":-11.313411,"median":-4.391806,"eighty":11.763889,"marketCap":1174029820},{"date":"2024-08-16","current":-14.644331,"twenty":-11.394446,"median":-4.394493,"eighty":11.665977,"marketCap":1185717919},{"date":"2024-08-23","current":-14.116672,"twenty":-11.499516,"median":-4.408355,"eighty":11.505529,"marketCap":1155817206},{"date":"2024-08-30","current":-13.991709,"twenty":-11.604234,"median":-4.420744,"eighty":11.371321,"marketCap":1142413438},{"date":"2024-09-06","current":-14.420895,"twenty":-11.657547,"median":-4.42489,"eighty":11.107418,"marketCap":1178500505},{"date":"2024-09-13","current":-15.793615,"twenty":-11.737773,"median":-4.432803,"eighty":2.94434,"marketCap":1284699588},{"date":"2024-09-20","current":-15.270478,"twenty":-11.804085,"median":-4.440792,"eighty":-2.401997,"marketCap":1253767816},{"date":"2024-09-27","current":-14.679623,"twenty":-11.914191,"median":-4.447593,"eighty":-2.427249,"marketCap":1209432277},{"date":"2024-10-04","current":-13.143706,"twenty":-11.959361,"median":-4.455656,"eighty":-2.444469,"marketCap":1067146127},{"date":"2024-10-11","current":-11.96416,"twenty":-12.011376,"median":-4.456647,"eighty":-2.454133,"marketCap":963524691},{"date":"2024-10-18","current":-12.336153,"twenty":-12.025407,"median":-4.457373,"eighty":-2.459907,"marketCap":984661402},{"date":"2024-10-25","current":-14.285975,"twenty":-12.044505,"median":-4.468177,"eighty":-2.461477,"marketCap":1137461784},{"date":"2024-10-31","current":-13.764523,"twenty":-12.128126,"median":-4.483246,"eighty":-2.463624,"marketCap":1101655012},{"date":"2024-11-08","current":-13.885712,"twenty":-12.169245,"median":-4.503904,"eighty":-2.468574,"marketCap":1104042130},{"date":"2024-11-15","current":-13.054871,"twenty":-12.169245,"median":-4.503904,"eighty":-2.468574,"marketCap":1018105878},{"date":"2024-11-22","current":-15.458345,"twenty":-12.203731,"median":-4.514379,"eighty":-2.468574,"marketCap":904717767},{"date":"2024-11-29","current":-16.871358,"twenty":-12.229129,"median":-4.531199,"eighty":-2.468574,"marketCap":993041137},{"date":"2024-12-06","current":-15.543989,"twenty":-12.325734,"median":-4.54255,"eighty":-2.468574,"marketCap":916653358},{"date":"2024-12-13","current":-15.11324,"twenty":-12.47605,"median":-4.571939,"eighty":-2.468574,"marketCap":884427263},{"date":"2024-12-20","current":-14.176503,"twenty":-12.536532,"median":-4.589061,"eighty":-2.468574,"marketCap":821168633},{"date":"2024-12-27","current":-14.50209,"twenty":-12.607094,"median":-4.61477,"eighty":-2.468574,"marketCap":842652696},{"date":"2025-01-03","current":-15.478086,"twenty":-12.675121,"median":-4.73663,"eighty":-2.468574,"marketCap":885620822},{"date":"2025-01-10","current":-14.484219,"twenty":-12.751315,"median":-4.816738,"eighty":-2.46748,"marketCap":831910664},{"date":"2025-01-17","current":-11.096948,"twenty":-12.796771,"median":-4.952365,"eighty":-2.46748,"marketCap":637360538},{"date":"2025-01-24","current":-11.445025,"twenty":-12.796771,"median":-4.993727,"eighty":-2.46748,"marketCap":664812396},{"date":"2025-01-31","current":-11.081854,"twenty":-12.796771,"median":-5.059605,"eighty":-2.46748,"marketCap":644521892},{"date":"2025-02-07","current":-11.649293,"twenty":-12.796771,"median":-5.086908,"eighty":-2.46748,"marketCap":674360868},{"date":"2025-02-14","current":-10.426073,"twenty":-12.796771,"median":-5.182542,"eighty":-2.46748,"marketCap":607521561},{"date":"2025-02-21","current":-9.403687,"twenty":-12.796771,"median":-5.259594,"eighty":-2.46748,"marketCap":549037167},{"date":"2025-02-28","current":-9.004543,"twenty":-12.796771,"median":-5.342284,"eighty":-2.46748,"marketCap":522778868},{"date":"2025-03-07","current":-9.481899,"twenty":-12.804479,"median":-5.382447,"eighty":-2.466386,"marketCap":572908348},{"date":"2025-03-14","current":-8.900746,"twenty":-12.804479,"median":-5.544447,"eighty":-2.466386,"marketCap":539488695},{"date":"2025-03-21","current":-10.449187,"twenty":-12.804479,"median":-5.595919,"eighty":-2.466386,"marketCap":632586301},{"date":"2025-03-28","current":34.222031,"twenty":-12.804479,"median":-5.635845,"eighty":-2.461782,"marketCap":562166317},{"date":"2025-04-04","current":27.708263,"twenty":-12.804479,"median":-5.635845,"eighty":-2.409314,"marketCap":466752648},{"date":"2025-04-11","current":28.351405,"twenty":-12.796771,"median":-5.631916,"eighty":11.621909,"marketCap":482554170},{"date":"2025-04-17","current":28.868636,"twenty":-12.796771,"median":-5.631916,"eighty":12.217934,"marketCap":499571194},{"date":"2025-04-25","current":32.850566,"twenty":-12.804479,"median":-5.635845,"eighty":12.692661,"marketCap":567639289},{"date":"2025-05-02","current":35.486356,"twenty":-12.804479,"median":-5.635845,"eighty":12.979613,"marketCap":608966346},{"date":"2025-05-09","current":30.744142,"twenty":-12.804479,"median":-5.635845,"eighty":13.456429,"marketCap":527527733},{"date":"2025-05-16","current":-22.75496,"twenty":-12.824569,"median":-5.687682,"eighty":13.620071,"marketCap":570070292},{"date":"2025-05-23","current":-25.01208,"twenty":-12.890727,"median":-5.806006,"eighty":13.620071,"marketCap":632060878},{"date":"2025-05-30","current":-25.98344,"twenty":-12.935524,"median":-5.882598,"eighty":13.620071,"marketCap":661232919},{"date":"2025-06-06","current":-27.394099,"twenty":-12.960135,"median":-6.058403,"eighty":13.620071,"marketCap":702559976},{"date":"2025-06-13","current":-28.790408,"twenty":-13.054871,"median":-6.289516,"eighty":13.620071,"marketCap":746318037},{"date":"2025-06-20","current":-27.684588,"twenty":-13.088754,"median":-6.399023,"eighty":13.631536,"marketCap":711068488},{"date":"2025-06-27","current":-25.93236,"twenty":-13.145324,"median":-6.595382,"eighty":13.631536,"marketCap":679465444},{"date":"2025-07-03","current":-26.3465,"twenty":-13.162126,"median":-6.736508,"eighty":13.631536,"marketCap":694051464},{"date":"2025-07-11","current":-27.860425,"twenty":-13.162126,"median":-6.736508,"eighty":13.631536,"marketCap":729301014},{"date":"2025-07-18","current":-29.081565,"twenty":-13.162126,"median":-6.736508,"eighty":13.631536,"marketCap":754826549},{"date":"2025-07-25","current":-29.739929,"twenty":-13.162126,"median":-6.736508,"eighty":13.631536,"marketCap":783998590},{"date":"2025-08-01","current":-30.601043,"twenty":-13.162126,"median":-6.736508,"eighty":13.631536,"marketCap":783998590},{"date":"2025-08-08","current":-29.490371,"twenty":-13.162126,"median":-6.736508,"eighty":13.631536,"marketCap":768197068},{"date":"2025-08-15","current":-8.234769,"twenty":-13.152088,"median":-6.736508,"eighty":13.631536,"marketCap":717201091},{"date":"2025-08-22","current":-7.883558,"twenty":-13.101408,"median":-6.736508,"eighty":13.631536,"marketCap":684380024},{"date":"2025-08-29","current":-7.362552,"twenty":-13.057275,"median":-6.736508,"eighty":13.631536,"marketCap":641834196},{"date":"2025-09-05","current":-7.990981,"twenty":-12.997161,"median":-6.713937,"eighty":13.643,"marketCap":695320380},{"date":"2025-09-12","current":-8.197221,"twenty":-12.995766,"median":-6.736508,"eighty":13.631536,"marketCap":719632281},{"date":"2025-09-19","current":-9.119319,"twenty":-12.995766,"median":-6.736508,"eighty":13.631536,"marketCap":803508341},{"date":"2025-09-26","current":-9.819216,"twenty":-12.995766,"median":-6.736508,"eighty":13.631536,"marketCap":856994524},{"date":"2025-10-03","current":-12.133561,"twenty":-12.995766,"median":-6.736508,"eighty":13.631536,"marketCap":1061214496},{"date":"2025-10-10","current":-15.3286,"twenty":-13.068148,"median":-6.736508,"eighty":13.631536,"marketCap":1324998626},{"date":"2025-10-17","current":-14.211501,"twenty":-13.088754,"median":-6.736508,"eighty":13.631536,"marketCap":1239906971},{"date":"2025-10-24","current":-14.26144,"twenty":-13.145324,"median":-6.736508,"eighty":13.631536,"marketCap":1237475781},{"date":"2025-10-31","current":-14.653579,"twenty":-13.179665,"median":-6.736508,"eighty":13.631536,"marketCap":1266650062},{"date":"2025-11-07","current":-13.010108,"twenty":-13.243186,"median":-6.736508,"eighty":13.631536,"marketCap":1121994249},{"date":"2025-11-14","current":-13.940682,"twenty":-13.312363,"median":-6.736508,"eighty":13.631536,"marketCap":1213163879},{"date":"2025-11-21","current":-8.866852,"twenty":-13.314837,"median":-6.736508,"eighty":13.631536,"marketCap":1227751020},{"date":"2025-11-28","current":-9.337499,"twenty":-13.314837,"median":-6.736508,"eighty":13.631536,"marketCap":1299517332},{"date":"2025-12-05","current":-10.311686,"twenty":-13.314837,"median":-6.789198,"eighty":13.631536,"marketCap":1442962650},{"date":"2025-12-12","current":-8.653784,"twenty":-13.314837,"median":-6.965094,"eighty":13.631536,"marketCap":1220500843},{"date":"2025-12-19","current":-8.256432,"twenty":-13.314837,"median":-7.104845,"eighty":13.631536,"marketCap":1163365843},{"date":"2025-12-26","current":-8.917209,"twenty":-13.314837,"median":-7.150971,"eighty":13.631536,"marketCap":1260616906},{"date":"2026-01-02","current":-9.056654,"twenty":-13.314837,"median":-7.235441,"eighty":13.631536,"marketCap":1276420204},{"date":"2026-01-09","current":-8.935233,"twenty":-13.314837,"median":-7.345942,"eighty":13.631536,"marketCap":1249474886},{"date":"2026-01-16","current":-9.547037,"twenty":-13.314837,"median":-7.467487,"eighty":13.631536,"marketCap":1329913183},{"date":"2026-01-23","current":-9.651587,"twenty":-13.314837,"median":-7.516018,"eighty":13.631536,"marketCap":1360747864},{"date":"2026-01-30","current":-8.78316,"twenty":-13.314837,"median":-7.602932,"eighty":13.631536,"marketCap":1257518716},{"date":"2026-02-06","current":-8.120448,"twenty":-13.314837,"median":-7.730525,"eighty":13.631536,"marketCap":1148927014},{"date":"2026-02-13","current":-9.320952,"twenty":-13.314837,"median":-7.818822,"eighty":13.631536,"marketCap":1327231907},{"date":"2026-02-20","current":-9.780412,"twenty":-13.314837,"median":-7.881231,"eighty":13.631536,"marketCap":1380857438},{"date":"2026-02-27","current":-9.59522,"twenty":-13.314837,"median":-7.989088,"eighty":13.631536,"marketCap":1358066587},{"date":"2026-03-06","current":-5.990291,"twenty":-13.314837,"median":-8.054182,"eighty":13.631536,"marketCap":1360747864},{"date":"2026-03-13","current":-5.57226,"twenty":-13.314837,"median":-8.054182,"eighty":13.631536,"marketCap":1261848780},{"date":"2026-03-20","current":-5.747258,"twenty":-13.314837,"median":-8.054182,"eighty":13.631536,"marketCap":1302077752},{"date":"2026-03-27","current":-5.782104,"twenty":-13.314837,"median":-8.054182,"eighty":13.631536,"marketCap":1310123547},{"date":"2026-04-02","current":-5.918675,"twenty":-13.314837,"median":-8.054182,"eighty":13.631536,"marketCap":1342306725},{"date":"2026-04-10","current":-6.220052,"twenty":-13.314837,"median":-8.054182,"eighty":13.631536,"marketCap":1429469500},{"date":"2026-04-17","current":-6.301034,"twenty":-13.314837,"median":-8.054182,"eighty":13.631536,"marketCap":1457629781},{"date":"2026-04-24","current":-6.497592,"twenty":-13.314837,"median":-8.054182,"eighty":13.631536,"marketCap":1495176822},{"date":"2026-05-01","current":-6.394601,"twenty":-13.314837,"median":-8.054182,"eighty":13.631536,"marketCap":1473721370},{"date":"2026-05-08","current":-6.460587,"twenty":-13.314837,"median":-8.054182,"eighty":13.631536,"marketCap":1493835856},{"date":"2026-05-15","current":-5.98498,"twenty":-13.314837,"median":-8.054182,"eighty":13.631536,"marketCap":1497858753},{"date":"2026-05-22","current":-5.970311,"twenty":-13.314837,"median":-8.054182,"eighty":13.631536,"marketCap":1483108130},{"date":"2026-05-29","current":-6.145032,"twenty":-13.315082,"median":-8.061914,"eighty":13.643,"marketCap":1535405795},{"date":"2026-06-05","current":-5.476813,"twenty":-13.314837,"median":-8.054182,"eighty":13.631536,"marketCap":1365103143},{"date":"2026-06-12","current":-5.011804,"twenty":-13.314837,"median":-8.054182,"eighty":13.631536,"marketCap":1238258838},{"date":"2026-06-18","current":-5.287507,"twenty":-13.314837,"median":-8.054182,"eighty":13.631536,"marketCap":1301128492},{"date":"2026-06-26","current":-5.333394,"twenty":-13.315082,"median":-8.061914,"eighty":13.643,"marketCap":1301811858},{"date":"2026-07-02","current":-5.48649,"twenty":-13.315082,"median":-8.061914,"eighty":13.643,"marketCap":1346230635},{"date":"2026-07-10","current":-5.55411,"twenty":-13.315082,"median":-8.061914,"eighty":13.643,"marketCap":1361264683},{"date":"2026-07-17","current":-5.237635,"twenty":-13.315082,"median":-8.061914,"eighty":13.643,"marketCap":1284727713},{"date":"2026-07-24","current":-5.208322,"twenty":-13.315082,"median":-8.061914,"eighty":13.643,"marketCap":1269693665},{"date":"2026-07-31","current":-5.093941,"twenty":-13.315327,"median":-8.07982,"eighty":13.654465,"marketCap":1257393081},{"date":"2026-08-07","current":-5.210949,"twenty":-13.315327,"median":-8.07982,"eighty":13.654465,"marketCap":1287461176},{"date":"2026-08-14","current":-5.298877,"twenty":-13.315327,"median":-8.07982,"eighty":13.654465,"marketCap":1310695613},{"date":"2026-08-21","current":-4.84397,"twenty":-13.315327,"median":-8.07982,"eighty":13.654465,"marketCap":1168555526},{"date":"2026-08-28","current":-5.317153,"twenty":-13.315327,"median":-8.07982,"eighty":13.654465,"marketCap":1279418184},{"date":"2026-08-31","current":-5.384539,"twenty":-13.315327,"median":-8.07982,"eighty":13.654465,"marketCap":1291720282}],"updateTime":1788279255853},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMTX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640594833","title":"Immatics announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640594833","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640594833?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:08","pubTimestamp":1780402086,"startTime":"0","endTime":"0","summary":"Immatics will hold its annual general meeting in Amsterdam on June 18, 2026.Shareholders will vote on items set out in the meeting agenda published on the company’s investor website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immatics NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDLbwgBBB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640951863","title":"Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640951863","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640951863?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:00","pubTimestamp":1780315200,"startTime":"0","endTime":"0","summary":"One-time infusion of anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy induced rapid, deep and durable systemic anti-tumor activity in metastatic PD-1 relapsed cutaneous melanoma and metas","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304266/0/en/Immatics-Presents-Clinical-Activity-and-Response-Dynamics-of-Anzu-cel-PRAME-Cell-Therapy-at-2026-ASCO-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169590202.USD","LU0963586101.USD","IMTX","LU1169589451.USD","BK4187","IE00B19Z4B17.USD","BK4139","PD","BK4023","IE0031619046.USD","CRS","LU2065731478.USD","IE00B7SZL793.SGD","IE00B66KJ199.SGD","BK4006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640986131","title":"Immatics announces presentation of extended data from Phase 1 trial of IMA401","url":"https://stock-news.laohu8.com/highlight/detail?id=2640986131","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640986131?lang=en_us&edition=fundamental","pubTime":"2026-06-01 05:30","pubTimestamp":1780263055,"startTime":"0","endTime":"0","summary":"Immatics (IMTX) announced the presentation of extended data from the ongoing Phase 1 clinical trial evaluating its TCR bispecific candidate IMA401 ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immatics-announces-presentation-of-extended-data-from-phase-1-trial-of-ima401-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immatics-announces-presentation-of-extended-data-from-phase-1-trial-of-ima401-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IMTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640198658","title":"Immatics announces updated Phase 1 data for its Prame TCR T-cell therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2640198658","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640198658?lang=en_us&edition=fundamental","pubTime":"2026-06-01 05:00","pubTimestamp":1780261206,"startTime":"0","endTime":"0","summary":"Immatics (IMTX) N.V. announced updated Phase 1 data for its IMA203CD8 PrameTCR T-cell therapy in gynecologic cancers and synovial sarcoma at the An...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immatics-announces-updated-phase-1-data-for-its-prame-tcr-t-cell-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immatics-announces-updated-phase-1-data-for-its-prame-tcr-t-cell-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639889529","title":"Immatics presents Phase 1 data for IMA401 MAGEA4/8 bispecific at ASCO 2026, supporting lung cancer combo study with IMA402","url":"https://stock-news.laohu8.com/highlight/detail?id=2639889529","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639889529?lang=en_us&edition=fundamental","pubTime":"2026-05-31 21:00","pubTimestamp":1780232421,"startTime":"0","endTime":"0","summary":"Immatics presented extended Phase 1 data on its IMA401 MAGEA4/8 TCR bispecific at the 2026 ASCO meeting, with simultaneous publication in Nature Medicine.The study showed durable tumor responses across several advanced solid tumors, supporting continued development of IMA401 as a standalone therapy.Safety appeared manageable, supporting use in combinations, including with pembrolizumab.The results underpinned a new Phase 1 cohort now enrolling in squamous non-small cell lung cancer testing IMA401 in combination with IMA402.First readouts from the IMA401/IMA402 combination cohort are expected in 2027.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nNDL1pPQ88:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BKPKM429.USD","SG9999014039.USD","IMTX","IE00BGHQF748.EUR","LU2210149790.SGD","NDAQ","IE00BN0W2V16.EUR","LU2210150020.SGD","LU2095319765.USD","BK4585","IE00B3QW5Z07.USD","BK4139","IE00BN0W2T93.GBP","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2W23.USD","BK4588","IE00B64PRP62.GBP","SG9999014021.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639798854","title":"Immatics posts ASCO presentation on PRAME-targeted TCR-T therapies in synovial sarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2639798854","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639798854?lang=en_us&edition=fundamental","pubTime":"2026-05-31 20:15","pubTimestamp":1780229753,"startTime":"0","endTime":"0","summary":"Immatics published a medical research presentation on Phase 1 results for PRAME-targeted TCR T-cell therapies anzu-cel  or IMA203CD8 in metastatic synovial sarcoma.Anzu-cel cohort (n=9) showed 56% objective response rate, 89% disease control at week 6, median duration of response 10.5 months.IMA203CD8 cohort  showed 67% objective response rate, 100% disease control at week 6, median duration of response 14.8 months.Safety profile centered on expected cytopenias; CRS was mostly grade 1-2, with grade 3 CRS in 2 IMA203CD8 patients; no HLH reported.Data cutoff was March 30, 2026; trial identifier IMA203-101 .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immatics NV published the original content used to generate this news brief on May 31","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nNDL7n3MFj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639609530","title":"Immatics reports 63% response rate in Phase 1 trial of IMA203CD8 PRAME T-cell therapy in hard-to-treat gynecologic cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2639609530","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639609530?lang=en_us&edition=fundamental","pubTime":"2026-05-30 20:01","pubTimestamp":1780142469,"startTime":"0","endTime":"0","summary":"Immatics released updated Phase 1 data for its IMA203CD8 PRAME T-cell therapy at the 2026 ASCO Annual Meeting.Results were presented May 30 in gynecologic cancers; additional synovial sarcoma data will be presented May 31.In hard-to-treat ovarian, uterine cancers, the one-time infusion produced meaningful tumor responses, including complete remissions in some patients.In heavily pretreated synovial sarcoma, the therapy delivered deep, durable responses, with some patients remaining in response for years.The safety profile appeared manageable, supporting continued development and a planned 2026 decision on a recommended Phase 2 dose.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nNDL7XbddK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SG9999014013.SGD","SG9999014021.USD","IMTX","IE00BN0W2W23.USD","NDAQ","LU2210150020.SGD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD","SG9999014039.USD","BK4588","IE00BKPKM429.USD","BK4112","LU2095319765.USD","LU2210149790.SGD","BK4139","IE00BGHQF748.EUR","LU0314104364.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639095506","title":"Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639095506","media":"GlobeNewswire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639095506?lang=en_us&edition=fundamental","pubTime":"2026-05-30 20:00","pubTimestamp":1780142400,"startTime":"0","endTime":"0","summary":"One-time infusion of IMA203CD8 PRAME cell therapy in the ongoing Phase 1 dose escalation/dose expansion trial achieved anti-tumor activity in platinum-resistant ovarian cancer and in uterine cancer wi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/30/3303876/0/en/Immatics-Presents-Clinical-Activity-of-IMA203CD8-PRAME-Cell-Therapy-in-Hard-to-Treat-Gynecologic-Cancers-at-2026-ASCO-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMTX","IE0031619046.USD","BK4187","BK4006","LU2065731478.USD","ORR","IE00B66KJ199.SGD","LU0963586101.USD","CRS","IE00B7SZL793.SGD","IE00B19Z4B17.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637383531","title":"How Investors May Respond To Immatics (IMTX) Wider Q1 Loss And Rising Funding Needs","url":"https://stock-news.laohu8.com/highlight/detail?id=2637383531","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637383531?lang=en_us&edition=fundamental","pubTime":"2026-05-21 14:42","pubTimestamp":1779345755,"startTime":"0","endTime":"0","summary":"Immatics N.V. has released its first-quarter 2026 results, reporting a net loss of €57.81 million, with basic and diluted loss per share from continuing operations of €0.43, compared with €0.33 in the prior-year period.\nThe widening loss suggests higher spending or lower income across Immatics’ operations, which may influence how investors view its ability to fund ongoing development.\nWith earnings pointing to a wider net loss, we’ll examine how this affects Immatics’ investment narrative...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-imtx/immatics/news/how-investors-may-respond-to-immatics-imtx-wider-q1-loss-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-imtx/immatics/news/how-investors-may-respond-to-immatics-imtx-wider-q1-loss-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IMTX","ISBC","BK4139","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636862990","title":"Immatics Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2636862990","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636862990?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:52","pubTimestamp":1779223920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 19, 2026 16:52 ET (20:52 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636886255","title":"Chardan Capital Reaffirms Their Buy Rating on Immatics (IMTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636886255","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636886255?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:35","pubTimestamp":1779222944,"startTime":"0","endTime":"0","summary":"In a report released today, Geulah Livshits from Chardan Capital reiterated a Buy rating on Immatics, with a price target of $25.00. According to T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/chardan-capital-reaffirms-their-buy-rating-on-immatics-imtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/chardan-capital-reaffirms-their-buy-rating-on-immatics-imtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635081883","title":"Immatics N.V. (NASDAQ:IMTX) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2635081883","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635081883?lang=en_us&edition=fundamental","pubTime":"2026-05-15 18:58","pubTimestamp":1778842736,"startTime":"0","endTime":"0","summary":"It's shaping up to be a tough period for Immatics N.V. ( NASDAQ:IMTX ), which a week ago released some disappointing...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-imtx/immatics/news/immatics-nv-nasdaqimtx-just-released-its-first-quarter-resul","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-imtx/immatics/news/immatics-nv-nasdaqimtx-just-released-its-first-quarter-resul","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SQQQ","TQQY","NDX","NQmain","QQQA","QYLG","TQQQ","IMTX","GPIQ","QQQY","JEPQ","QQQE","MNQmain","QQQJ","PSQ","QQQM","NVIW.SI","FTEC",".IXIC","QDTE","BK4139","QLD","QID","ONEQ","TECS","IYW","QQQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635747859","title":"Analysts Offer Insights on Healthcare Companies: Immatics (IMTX) and Cormedix (CRMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635747859","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635747859?lang=en_us&edition=fundamental","pubTime":"2026-05-15 02:00","pubTimestamp":1778781628,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Immatics (IMTX) and Cormedix (CRMD) with bullish sen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immatics-imtx-and-cormedix-crmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immatics-imtx-and-cormedix-crmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMTX","HCSG","BK4581","BK4585","BK4137","LU0128526141.USD","LU0029874061.USD","XLV","BK4007","BK4139","XBI","BK4588","CRMD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179319369","title":"Stock Track | Immatics Soars 5.18% in Pre-market After Goldman Sachs Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1179319369","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179319369?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:02","pubTimestamp":1778670149,"startTime":"0","endTime":"0","summary":"Immatics N.V. (IMTX) saw its stock price surge 5.18% during pre-market trading on Wednesday, following positive analyst coverage from Goldman Sachs.The investment bank maintained a Buy rating on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IMTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635776862","title":"Immatics (IMTX) Gets a Buy from Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2635776862","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635776862?lang=en_us&edition=fundamental","pubTime":"2026-05-13 14:15","pubTimestamp":1778652920,"startTime":"0","endTime":"0","summary":"In a report released today, Rajan Sharma from Goldman Sachs maintained a Buy rating on Immatics, with a price target of $12.20. Sharma covers the H...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/immatics-imtx-gets-a-buy-from-goldman-sachs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/immatics-imtx-gets-a-buy-from-goldman-sachs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMTX","LU1868836757.USD","BK4516","LU2237443382.USD","IE00BFXG1179.USD","BK4139","LU2237443465.HKD","LU2237443622.USD","BK4533","IE0034235188.USD","LU2237443978.SGD","LU2471134796.USD","LU1804176565.USD","LU1868837136.USD","LU1894683264.USD","BK4552","BK4504","LU2750360641.GBP","LU1868836914.USD","LU1894683348.USD","BK4585","LU0106831901.USD","IE0004091025.USD","BK4127","IE0002270589.USD","LU2237438978.USD","LU1668664300.SGD","GSX","LU1868837300.USD","BK4550","LU0061475181.USD","LU2471134952.CNY","IE00BSNM7G36.USD","LU0096364046.USD","LU2471134879.HKD","LU2237443895.HKD","LU2265009873.SGD","IE0004086264.USD","LU0742534661.SGD","LU0048573561.USD","LU1791807156.HKD","BK4588","LU0345770993.USD","IE00B19Z3581.USD","LU0251131958.USD","LU1868836591.USD","LU2471134523.USD","LU2750360997.AUD","LU0251142724.SGD","LU0345770308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634124032","title":"Immatics NV reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2634124032","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634124032?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:30","pubTimestamp":1778592612,"startTime":"0","endTime":"0","summary":"Immatics NV reports results for the quarter ended March 31 - Earnings SummaryImmatics NV IMTX.OQ reported a quarterly adjusted loss of 43 cents per share for the quarter ended March 31, lower than the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL8N41P1XR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634215221","title":"Immatics Q1 Loss Widens, Revenue Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2634215221","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634215221?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:40","pubTimestamp":1778586051,"startTime":"0","endTime":"0","summary":"Immatics  reported a Q1 net loss Tuesday of 0.43 euros  per diluted share, widening from a loss of 0.33 euros a year earlier.Four analysts surveyed by FactSet expected a loss of 0.45 euros.Revenue from collaboration agreements for the quarter ended March 31 was 7.6 million euros, down from 18.6 million euros a year earlier.Analysts polled by FactSet expected 8.5 million euros.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634215584","title":"Immatics Q1 EPS $(0.50) Misses $(0.42) Estimate, Sales $8.914M Miss $14.590M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2634215584","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634215584?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:29","pubTimestamp":1778585343,"startTime":"0","endTime":"0","summary":"Immatics (NASDAQ:IMTX) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.42) by 19.05 percent. This is a 42.86 percent decrease over losses of $(0.35) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52480733/immatics-q1-eps-0-50-misses-0-42-estimate-sales-8-914m-miss-14-590m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634139602","title":"Earnings Flash (IMTX) Immatics Posts Q1 Net Loss 0.43 Euro a Share, vs. FactSet Est of 0.45 Euro Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2634139602","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634139602?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:13","pubTimestamp":1778584410,"startTime":"0","endTime":"0","summary":"Earnings Flash (IMTX) Immatics Posts Q1 Net Loss 0.43 Euro a Share, vs. FactSet Est of 0.45 Euro Loss","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMTX","FXE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634451218","title":"Press Release: Immatics Announces First Quarter 2026 Financial Results and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2634451218","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634451218?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583600,"startTime":"0","endTime":"0","summary":"-- SUPRAME Phase 3 interim and final analysis for PRAME cell therapy,anzu-cel, expected to be triggered in 2026, advancing toward the. -- Multiple key clinical data sets expected in 2026 across the portfolio,including four clinical-stage cell therapy and bispecific candidates. targeting cutaneous and uveal melanoma, gynecologic cancers (ovarian and. uterine), head and neck cancer, and other solid tumor indications. -- Phase 1 data readout with second-generation PRAME cell therapy,IMA203CD8, to be presented at the 2026 ASCO meeting, focusing on. -- Phase 1b clinical data from PRAME bispecific, IMA402, as monotherapy and. initial data in combination with an immune checkpoint inhibitor at RP2D. bispecifics, IMA402 targeting PRAME and IMA401 targeting MAGEA4/8 in. -- Cash and cash equivalents as well as other financial assets of $521.5. million1  as of March 31, 2026; cash reach projected. Anzu-cel , previously called IMA203, is Immatics' lead PRAME cell therapy and is expected to be the C","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4195","PFS","IMTX","ORR","BK4211","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":70,"code":"91000000","status":"200"}]}}